Effectiveness of the influenza vaccine at preventing hospitalization due to acute lower respiratory infection and exacerbation of chronic cardiopulmonary disease in Korea during 2010-2011

Vaccine

Volumn 31, Issue 10, 2013, Pages 1426-1430

  Seo, Yu Bin ^a   Hong, Kyoung Wook ^a   Kim, In Seon ^a   Choi, Won Suk ^a   Baek, Ji Hyeon ^b   Lee, Jacob ^c   Song, Joon Young ^a   Lee, Jin Soo ^b   Cheong, Hee Jin ^a   Kim, Woo Joo ^a,d  

^a Korea University College of Medicine   (South Korea)

^b Inha University School of Medicine   (South Korea)

^c Hallym University College of Medicine   (South Korea)

^d Korea University Hospital   (South Korea)

Author keywords

Case control study; Chronic cardiovascular disease; Chronic respiratory disease; Effectiveness; Influenza vaccine; Korea

Indexed keywords

INFLUENZA VACCINE;

ACUTE LOWER RESPIRATORY INFECTION; ADULT; AGE; AGED; ARTICLE; ASTHMA; BODY MASS; BRONCHIOLITIS; BRONCHITIS; CASE CONTROL STUDY; CHRONIC CARDIOPULMONARY DISEASE; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENDER; HEART FAILURE; HOSPITALIZATION; HUMAN; INFLUENZA VACCINATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY;

ADULT; AGED; BRONCHOPNEUMONIA; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PNEUMONIA, VIRAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES;

EID: 84875805358     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.10.024     Document Type: Article

References (18)

1. Reichert T.A., Simonsen L., Sharma A., Pardo S.A., Fedson D.S., Miller M.A. Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epidemiol 2004, 160(September (5)):492-502.
2. Wong C.M., Chan K.P., Hedley A.J., Peiris J.S. Influenza-associated mortality in Hong Kong. Clin Infect Dis 2004, 39(December (11)):1611-1617.
3. Nichol K.L., Wuorenma J., von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 1998, 158(September (16)):1769-1776.
4. Izurieta H.S., Thompson W.W., Kramarz P., Shay D.K., Davis R.L., DeStefano F., et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000, 342(January (4)):232-239.
5. Kee S.Y., Lee J.S., Cheong H.J., Chun B.C., Song J.Y., Choi W.S., et al. Influenza vaccine coverage rates and perceptions on vaccination in South Korea. J Infect 2007, 55(September (3)):273-281.
6. Nichol K.L., Nordin J., Mullooly J., Lask R., Fillbrandt K., Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003, 348(April (14)):1322-1332.
7. Epstein S.E., Zhou Y.F., Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 1999, 100(July (4)):e20-e28.
8. Naghavi M., Wyde P., Litovsky S., Madjid M., Akhtar A., Naguib S., et al. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation 2003, 107(February (5)):762-768.
9. Mullooly J.P., Bridges C.B., Thompson W.W., Chen J., Weintraub E., Jackson L.A., et al. Influenza- and RSV-associated hospitalizations among adults. Vaccine 2007, 25(January (5)):846-855.
10. Phrommintikul A., Kuanprasert S., Wongcharoen W., Kanjanavanit R., Chaiwarith R., Sukonthasarn A. Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. Eur Heart J 2011, 32(July (14)):1730-1735.
11. Foster D.A., Talsma A., Furumoto-Dawson A., Ohmit S.E., Margulies J.R., Arden N.H., et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol 1992, 136(August (3)):296-307.
12. Fleming D.M., Watson J.M., Nicholas S., Smith G.E., Swan A.V. Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database. Epidemiol Infect 1995, 115(December (3)):581-589.
13. Tessmer A., Welte T., Schmidt-Ott R., Eberle S., Barten G., Suttorp N., et al. Influenza vaccination is associated with reduced severity of community-acquired pneumonia. Eur Respir J 2011, 38(July (1)):147-153.
14. von Baum H., Schweiger B., Welte T., Marre R., Suttorp N., Pletz M.W., et al. How deadly is seasonal influenza-associated pneumonia? The German competence network for community-acquired pneumonia. Eur Respir J 2011, 37(May (5)):1151-1157.
15. Poole P.J., Chacko E., Wood-Baker R.W., Cates C.J. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006, (1). [CD002733].
16. Cates C.J., Jefferson T.O., Rowe B.H. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst Rev 2008, (2). [CD000364].
17. Jackson L.A., Yu O., Heckbert S.R., Psaty B.M., Malais D., Barlow W.E., et al. Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am J Epidemiol 2002, 156(October (7)):634-640.
18. Simonsen L., Taylor R.J., Viboud C., Miller M.A., Jackson L.A. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007, 7(October (10)):658-666.